Auriga upgrades Allscripts Healthcare Solutions (Nasdaq: MDRX) from 'Hold' to 'Buy' while raising the price target from $19 to $20 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE